If patients have to go back on drugs anyway, then what’s the point?

NeuroStar is used for the acute treatment of patients with depression who have not received satisfactory improvement from prior antidepressant treatment.

• Most patients who benefited from TMS were able to retain effect for up to 6 months on only one antidepressant medication at a minimal dose.
  These patients had failed a median of 4 antidepressant treatment attempts, one adequate treatment.
• In the open-label trial, which is most like the real world, among NeuroStar-treated patients, ~1in 2 achieved a significant improvement in symptoms and 1in 3 had complete symptom resolution.
• Since NeuroStar is non-systemic, these results were achieved without side effects such as weight gain, sexual dysfunction, nausea, dry mouth, sedation, etc.